Pharmacists are integral to oncology care, optimizing treatment plans, managing adverse effects, and supporting precision medicine through collaborative practice agreements.

New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...

The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage leader in regenerative and cellular innovation, today announced the official launch of ...

Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement ...

Researchers have uncovered microbial evidence in the remains of Napoleon’s soldiers from the 1812 Russian retreat. Genetic ...

Sequencing genomic material extracted from the teeth of 13 soldiers in Napoleon’s troops highlighted that more diseases than ...

Genomics has administered a double dose of litigation to Illumina, joining with separate partners in a pair of federal lawsuits accusing the sequencing giant of infringing on nine patents related to ...

In a breakthrough that redefines both speed and clinical potential, a new world record for the fastest human whole genome ...

Illumina is rated a BUY as it drives growth with AI, multiomics, and strategic acquisitions. Click here to read my earnings ...

TUESDAY, Oct. 29, 2024 (HealthDay News) -- Genome sequencing of newborns is both feasible and acceptable for parents of a diverse newborn population, according to a study published online Oct. 24 in ...